Recurrent Airway Obstruction in Horse: Case Study Report

perennial Airway Obstruction in Horse Case remove ReportA 12-year-old Thoroughbred gelding was examined for a spit out whilst macrocosm stabled over the winter. There was limited useable turnout so the sawbuck remained stabled on shavings in a stable barn. The provide was fed ironic hay. There was no previous history of coughing.The clinical examination was unremarkable. The proprietor described an intermittent dry cough occurring at expect and exercise. At this time the owner was advised to introduce environmental changes to overturn clean exposure. The vaulting horse was moved to a stable away from the hay interpose and started on soaked hay. An inflammatory blood profile was taken which revealed no anomalousities.Despite implementation of environmental changes the cough persisted. The horse was re-examined two months ulterior at the clinic. On this occasion the horse presented with a bilateral mucopurulent in straitened circumstances(p) discharge and persistent coug h. The horse was tachypneic (25 breaths per minute) with profitd abdominal military campaign the remainder of the clinical examination was unremarkable. A re-breathing examination was performed to aid auscultation of abnormal lung sounds there were no adventitious sounds and the trachea was normal on auscultation. enigma listIntermittent cough at exercise and at restMucopurulent nasal dischargeRecurrent episodesTachypneicDifferential Diagnosis slantRecurrent air passage obstruction (RAO)Inflammatory respiratory tract illnessviral infection broncpneumoniaPulmonary neoplasiaLungwormThe signalment and history alongside the clinical signs of coughing, nasal discharge, laboured respiratory effort and exercise intolerance in the absence of pyrexia, suggested RAO. An endoscopic examination of the upper and dismantle airways to mensurate tracheal secretions and to stick a fluid sample for a tracheal wash was performed. Endoscopy revealed upheaval of the pharyngeal recess, mild ly mphoid hyperplasia, erythema of the trachea and a thickened carina. The tracheal wash (TW) sample was mucoid.The cytology report from the TW indicated chronic irritation and redness until now the carrell populations were unable to indicate a specific underlying aetiology. Neutrophillic inflammation was non a strong feature withal starting time-moderate levels of macrophages and Curschman spirals were present, both of which smoke be associated with RAO. Bacterial culture yielded a s basist growth of Enterobacter spp and Pasteurella spp photosensitive to trimethoprim sulphonamides word for a possible bacterial tracheitis was initiated alongside a mucolytic for the mucous secretion present in the airway. Dembrexine hydrochloride (Sputolosin, Boerhinger Ingleheim) (0.3mg/kg q12h PO) and trimethoprim sulfadiazine (Trimediazine Plain, veterinary surgeonquinol) (30mg/kg q12h PO) were administered for 10days followed by re-examination. A Broncho alveolar lavage (BAL) was advised i n order to determine the charge of lower airway inflammation specifically however the horse was improving and the knob declined at this time.Improvement was seen initially however after 5months following initial presentation the cough and nasal discharge resumed. The clinical examination was once more unremarkable. A thick muco-purulent TW sample was obtained which revealed marked neutrophilic inflammation 95% of the nucleated cells and a negative bacterial culture. These results were consistent with RAO and as a result interference for RAO was initiated. Inhaled salbutamol (400ug q12h) followed 5minutes later by beclomethas atomic number 53 (3000ug q12h) for 6weeks. This was administered using a MDI and an AeroHippus, equid Aerosol domiciliate (Trundell Medical). A decision was made to perform a BAL 6weeks later to assess response to treatment.On re-examination the nasal discharge had ceased with a quietus cough only at exercise. The BAL sample at this time revealed A residual cough persisted despite being on continuous treatment. As a result a Flexineb nebuliser was trialled. Dexamethasone was utilise as the inhaled agent 0.5ml unfertile water with 0.5ml dexamethasone (Dexadresson, Intervet) once daily for two weeks and then all(prenominal) other day for two weeks.DiscussionRAO is a common disease of older usually stabled horses. Hotchkiss et al, 2007 reported an estimated disease prevalence of 14% in the UK (Hotchkiss et al, 2007). The history, signalment and clinical signs presented in this case supported a diagnosing of RAO (Leclere et al, 2011).The clinical signs most likely represent hypersensitivity/exaggerated response to inhaled pro-inflammatory agents much(prenominal) as hay break up, moulds, spores, forage mites, endotoxins and inorganic components which cause significant distal airway inflammation in susceptible horses (Robinson and Chairperson, 2001). The relative importance of these allergens in the aetiopathogenesis of RAO is difficul t to determine its likely all contribute done an additive and/or synergistic mechanism (Pirie et al, 2003).Endoscopic examination revealed b ar(a) mucus as a result of neutrophilic inflammation and a blunt carina receivable to oedema and remodelling (Koblinger et al, 2011). Changes within the airway result from mucus metaplasia, serene muscle hypertrophy and fibrosis. Bronchospasm of the airway alongside mucus and neutrophil assemblage leads to obstruction (Robinson et al, 2000). The initial treatment with a mucolytic, dembrexine hydrochloride (Sputolosin, Boerhinger Ingleheim) initially provided improvement in clinical signs by fragmenting the sputum fibre network so cut back mucus viscoelasticity (Matthews, Hackett and Lawton, 1988).The owner was reluctant to perform a BAL initially due to the increased stress to the horse. The initial TW cytology couldnt confirm a diagnosis despite the presence of Curschmanns spirals which can indicate RAO (Reed and Bayly, 1998). Although its serious to interpret culture results in light of cytology and clinical signs, paying slight attention to scanty mixed growths of bacteria, the culture results were used to direct initial treatment for a possible bacterial tracheitis (McGorum, 2007). In this case where the clinical signs and signalment supported RAO a BAL alongside the TW would have provided a more time-tested diagnosis. A BAL is more representative of the lower airways as it allows elucidation of the cellular response to lung injury (Derksen et al, 1989). Macrophages and lymphocytes are the predominant cell populations in BAL in normal horses whereas RAO is characterised by a non-septic inflammatory reaction, 25% neutrophils of the total nucleated cell count (Robinson, 2001).Management of this disease involves three principles environmental authority to reduce allergens, corticosteroids to reduce inflammation and bronchodilators to relieve respiratory distress (Durham, 2001). It can be difficult to persuade owners that environmental changes are as important as medical treatment. In many cases clinical remission can be achieved by moving horses to either pasture or an indoor low-airborne dust environment (Vandenput et al, 1998). Green pasture is the best option to reduce clinical signs and horses should remain outdoors at all times with a supplementary pelleted diet this was not practicable in this case (Jackson et al, 2000). The limited available turnout during winter made management problematic. Bedding on rubber eraser matting in conjunction with cardboard and shredded paper provides the low dust levels for a stabled horse (Tanner et al, 1998). In most horses with RAO the main starting time of dust is from hay and litter in this case the horse had originally been stabled adjacent to the hay barn. Soaking hay reduces the dust challenge however not sufficiently to resolve symptoms of RAO (Clements and Pirie, 2007).Treatment is based around a combination of bronchodilators and cor ticosteroids. Bronchodilators aim to alleviate respiratory distress associated with bronchospasm. Clenbuterol a B2 adrenergic agonist is most commonly administered orally to effect (Erichsen et al, 1994). In summation to its bronchodilator effect, clenbuterol has alike been shown to have an anti-inflammatory effect (Lann et al, 2006). The efficacy of inhaled B2 adrenergic agonists has also been recognised, inducing a rapid, significant bronchodilation in horses demonstrating RAO (Bertin et al, 2011).Due to the tellingness lay out with inhaled agents in human patients, this route was investigated in horses. By using bronchodilators anterior to brass of corticosteroids a deeper penetration of inhaled drug can be achieved (Rush et al, 1998). The horses demeanour in this case made him suitable for inhaled medications and he tolerated treatment well.The advantage of inhaled corticosteroids is that a higher concentration of drug can be administered locally to the airways leading to a rapid onset of action, cut down the dose required and the subsequent side effects associated with corticosteroids (Duvvier et al, 1997). In blunt cases general steroids are used initially to improve lung last as inhaled steroids require good pulmonary distribution to be effective (Ammann et al, 2008).MDI are not licensed for horses and therefore they were used with due consideration of the come down and the owners informed consent for the use of off-label medications according to Section 4.17 of the Supporting way to the RCVS Code of Professional Conduct (RCVS, 2014). They are most efficient and effective when used with a spacer which directs flow of the drug through a one way valve which opens on inspiration. The AeroHippus EAC, (Trundell Medical) is designed to be used with a MDI. The presence of the Flow-Vu indicator enables owners to count the number of breaths the horse has taken through the chamber and ensures a satisfactory seal, both of which aid the correct and op timal economy of the drug to the lungs (Trundell Medical International, 2015).Nebulisers can also be used to lurch aerosol medication. Nebulisation has been shown to improve drug concentration in the lungs while minimising systemic concentrations and potential toxicity (Sustronck et al, 1995). Fultz et al (2014) demonstrated that saving via nebulization can increase the concentration of a drug in the pulmonary epithelial cladding fluid (PELF) (Fultz et al, 2014). A Flexineb nebuliser was tried with this case due to its chronic record and the clinical signs subsequently resolved.Although the mainstay of treatment is corticosteroids, recurrence of clinical signs allow for recur within 3days of treatment cessation if environment improvements are not made (Jackson et al, 2000). There is evidence of persistent chronic peripheral airway obstruction, in the absence of neutrophilic airway inflammation, even when RAO cases are maintained in a low dust environment. This supports the evi dence for development of irreversible ultrastructural changes in the lung induced by prolonged repeated exacerbation, but also low grade airway inflammation (Miskovic et al, 2007). In these cases thoracic radiographs should be used to rule out irreversible lung pathology (Lavoie et al, 2004).BibliographyAmmann, V., Vrins, A. and Lavoie, J. (1998). Effects of inhaled beclomethasone dipropionate on respiratory usage in horses with chronic obstructive pulmonary disease (COPD). Equine veterinary Journal, 30(2), pp.152-157.Bertin, F., Ivester, K. And Coutil, L. (2011). Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. Equine ex-serviceman Journal, 43(4), pp.393-398.Clements, J. and Pirie, R. (2007). Respirable dust concentrations in equine stables. Part 2 The benefits of soaking hay and optimising the environment in a neighbouring stable. Research in ex-serviceman Science, 83(2), pp.263-268.Derksen, F., Brow n, C., Sonea, I., Darien, B. and Robinson, N. (1989). Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine vet Journal, 21(1), pp.23-26.Durham, A. (2001). Update on therapeutics for obstructive pulmonary diseases in horses. In Practice, 23(8), pp.474-481.Duvivier, D., Votion, D., Vandenput, S. and Lekeux, P. (1997). Aerosol therapy in the equine species. The veterinary Journal, 154(3), pp.189-202.Fairbairn, S., Lees, P., Page, C. and Cunningham, F. (1993). Duration of antigen-induced hyperresponsiveness in horses with allergic respiratory disease and possible link up with early airway obstruction. Journal of veterinary surgeon Pharmacology and Therapeutics, 16(4), pp.469-476.Fultz, L., Gigure, S., Berghaus, L., Grover, G. and Merritt, D. (2014). Pulmonary pharmacokinetics of desfuroylceftiofur acetamide after nebulisation or intramuscular administration of ceftiofur sodium to weanling foals. Equine Vet Journal, ar ticle first published online 5 September 2014Hotchkiss, J., Reid, S. and Christey, R. (2007). A survey of horse owners in Great Britain regarding horses in their care. Part 1 Horse demographic characteristics and management. Equine Veterinary Journal, 39(4), pp.294-300.Hoffman, A. (2008). Bronchoalveolar Lavage Sampling Technique and Guidelines for Cytologic Preparation and Interpretation. Veterinary Clinics of North America Equine Practice, 24(2), pp.423-435.Gerber, V., King, M., Schneider, D. and Robinson, N. (2000). Tracheobronchial mucus viscoelasticity during environmental challenge in horses with recurrent airway obstruction. Equine Veterinary Journal, 32(5), pp.411-417.Jackson, C.A., Berney, C., Jefcoat, A.M. and Robinson, N.E. (2000). Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine Veterinary Journal. 32, pp432-438.Koblinger, K., Nicol, J., McDonald, K., Wasko, A., Logie, N., Weiss, M. and Lguillette, R. (2011). Endos copic Assessment of Airway Inflammation in Horses. Journal of Veterinary immanent Medicine, 25(5), pp.1118-1126.Laan, T., Bull, S., Pirie, R. and Fink-Gremmels, J. (2006). The anti-inflammatory effects of IV administered clenbuterol in horses with recurrent airway obstruction. The Veterinary Journal, 171(3), pp.429-437.Lavoie, J., Dalle, S., Breton, L. and Hlie, P. (2004). Bronchiectasis in Three Adult Horses with Heaves. Journal of Veterinary Internal Medicine, 18(5), pp.757-760.Leclere, M., Lavoie-Lamoureux, A. and Lavoie, J. (2011). Heaves, an asthma-like disease of horses. Respirology, 16(7), pp.1027-1046.Matthews, A., Hackett, I. and Lawton, W. (1988). The mucolytic effect of Sputolosin in horses with respiratory disease. Veterinary Record, 122(5), pp.106-108.McGorum, B. (2007). Equine respiratory medicine and surgery. Saunders Elsevier. (5) pp565-590Miskovic, M., Coutil, L. and Thompson, C. (2007). Lung Function and Airway Cytologic Profiles in Horses with Recurrent Airway Ob struction Maintained in Low-Dust Environments. Journal Veterinary Internal Medicine, 21(5), p.1060.Pirie, R., Collie, D., Dixon, P. and McGorum, B. (2003). Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clinical Experimental Allergy, 33(5), pp.676-683Rcvs.org.uk, (2014). 4. Veterinary medicines RCVS. online Available at http//www.rcvs.org.uk/advice-and-guidance/code-of-professional-conduct-for-veterinary-surgeons/supporting-guidance/veterinary-medicines/ Accessed 18 Feb. 2015.Reed, S. and Bayly, W. (1998). Equine internal medicine. Philadelphia Saunders. Chapter 9, pp341Robinson, N.E., Olszewski, M.A., Boehler, D., Berney, C., Hakala, J., Matson, C. and Derksen, F.J. (2000). Relationship between clinical signs and lung function in horses with recurrent airway obstruction (heaves) during a bronchodilator trial. Equine Veterinary Journal. 32, pp393-400.Robinson, N. and Chairperson, W. (2001). In ternational Workshop on Equine Chronic Airway sickness Michigan State University 16-18 June 2000. Equine Veterinary Journal, 33(1), pp.5-19.Rush, B., Raub, E., Rhodes, W. S., et al. (1998). Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. American Journal of Veterinary Research, 59, pp1039-1043Sustronck, B., Deprez, P., Muylle, E., Vermeersch, H., Vandenbossche, G. and Remon, J. (1995). Evaluation of the nebulisation of sodium ceftiofur in the treatment of experimental Pasteurella haemolytica bronchopneumonia in calves. Research in Veterinary Science, 59(3), pp.267-271.Tanner, M., Swinker, A., Traub-Dargatz, J., Stiffler, L., McCue, P., Vanderwall, D., Johnson, D. and Vap, L. (1998). respiratory and environmental effects of recycled phone book paper versus sawdust as bedding for horses. Journal of Equine Veterinary Science, 18(7), pp.468-476.Trundell Medical Int ernational (2015) AeroHippus. http//www.trundellmed.com/animal-health/aerohippus 4 February 2015Vandenput, S., Duvivier, D., Votion, D., Art, T. and Lekeux, P. (1998). Environmental control to maintain stabled COPD horses in clinical remission effects on pulmonary function. Equine Veterinary Journal, 30(2), pp.93-96.